| Literature DB >> 34796460 |
Vishal Uppal1, Harsha Shanthanna2, Hari Kalagara3, Rakesh V Sondekoppam4, Sameh M Hakim5, Meg A Rosenblatt6, Amit Pawa7, Alan J R Macfarlane8, Eleni Moka9, Samer Narouze10,11.
Abstract
PURPOSE: To determine the preferences and attitudes of members of regional anesthesia societies during the COVID-19 pandemic.Entities:
Keywords: COVID-19; SARS-CoV-2; anesthesia; nerve block; regional anesthesia; surveys and questionnaires
Mesh:
Year: 2021 PMID: 34796460 PMCID: PMC8601752 DOI: 10.1007/s12630-021-02150-8
Source DB: PubMed Journal: Can J Anaesth ISSN: 0832-610X Impact factor: 6.713
Personal characteristics of participants
| Variable | % | |
|---|---|---|
| Age quartile | ||
| < 40 yr | 146/624 | 23.4% |
| 40-44 yr | 145/624 | 23.2% |
| 45-52 yr | 167/624 | 26.8% |
| ≥ 53 yr | 166/624 | 26.6% |
| Gender | ||
| Male | 395/623 | 63.4% |
| Female | 223/623 | 35.8% |
| Prefer not to answer | 5/623 | 0.8% |
| Category of practitioner | ||
| Staff/faculty/consultant | 521/594 | 87.7% |
| Certified registered nurse anesthetist (CRNA) | 5/594 | 0.8% |
| Anesthesia assistant | 9/594 | 1.5% |
| Nurse | 1/594 | 0.2% |
| Fellow | 16/594 | 2.7% |
| Resident/trainee | 36/594 | 6.1% |
| Other | 6/594 | 1.0% |
| Practice setting | ||
| Academic institute or university hospital | 332/729 | 45.5% |
| Military/Veterans Affairs hospital | 15/729 | 2.1% |
| Community hospital | 202/729 | 27.7% |
| Private clinic | 116/729 | 15.9% |
| Other settings | 29/729 | 4.0% |
| Country of practice | ||
| Americas | 136/619 | 22.0 |
| Europe | 273/619 | 44.1 |
| UK | 99/619 | 16.0 |
| Asia | 87/619 | 14.1 |
| Africa | 15/619 | 2.4 |
| Australia and New Zealand | 9/619 | 1.5 |
| Area of anesthesia practice | ||
| Predominantly obstetric anesthesia | 10/619 | 1.6% |
| A mix of obstetric and non-obstetric anesthesia | 342/619 | 55.3% |
| Non-obstetric anesthesia | 267/619 | 43.1% |
| Subspecialty of anesthesia practice | ||
| Orthopedic surgery | 563/729 | 77.2% |
| Trauma surgery | 449/729 | 61.6% |
| Plastic surgery | 350/729 | 48.0% |
| General surgery including urology | 507/729 | 69.5% |
| Other areas | 122/729 | 16.7% |
Data are presented as valid number/total number (n/total N) and valid percentage (%)
FigureThe practice of regional anesthesia during the COVID-19 pandemic: an international survey of members of three regional anesthesia societies
Changes in participants' practice for neuraxial anesthesia and peripheral nerve blocks during the height of the COVID-19 pandemic
| Survey question | % | |
|---|---|---|
| The clinical indications for my use of neuraxial anesthesia during the height of the COVID-19 pandemic | ||
| Expanded | 311/599 | 51.9% |
| Stayed the same | 276/599 | 46.1% |
| Decreased | 12/599 | 2.0% |
| What are your reasons for the increase in use? | ||
| To reduce aerosol-generating medical procedures | 308/311 | 99.0% |
| To reduce the risk of possible complications to patients | 179/311 | 57.6% |
| To allow early discharge from hospitals | 125/311 | 40.2% |
| To conserve PPE | 138/311 | 44.4% |
| Other reasons | 16/311 | 5.1% |
| What are the reasons for the decrease in use? | ||
| Risk of SARS-CoV-2 transmission to healthcare professional by an awake patient | 5/12 | 41.7% |
| Unclear evidence on the benefit of neuraxial anesthesia for a patient with SARS-CoV-2 infection | 2/12 | 16.7% |
| Risk of urgent conversion to GA for a patient with SARS-CoV-2 infection | 7/12 | 58.3% |
| Other reasons | 4/12 | 33.3% |
| The clinical indications for my use of peripheral nerve block for surgical anesthesia (without GA) during the height of the COVID-19 pandemic: | ||
| Expanded | 244/534 | 45.7% |
| Stayed the same | 277/534 | 51.9% |
| Decreased | 13/534 | 2.4% |
| What are your reasons for the increase in use? | ||
| To reduce aerosol-generating medical procedures | 240/244 | 98.4% |
| To reduce the risk of possible complications to patients | 156/244 | 63.9% |
| To allow early discharge from hospitals | 150/244 | 61.5% |
| To conserve PPE | 119/244 | 48.8% |
| What are the reasons for the decrease in use? | ||
| Risk of SARS-CoV-2 transmission to healthcare professional by an awake patient | 6/13 | 46.2% |
| Unclear evidence on the benefit of neuraxial anesthesia for a patient with SARS-CoV-2 infection | 1/13 | 7.7% |
| Risks of complications of peripheral nerve blocks outweigh the benefits | 1/13 | 7.7% |
| Risk of urgent conversion to GA for a patient with SARS-CoV-2 infection | 5/13 | 38.5% |
| Other reasons | 5/13 | 38.5% |
Data are presented as valid number / total number (n/total N) and valid percentage (%)
GA = general anesthesia; NAB = neuraxial block; PNB = peripheral nerve block; PPE = personal protective equipment
Strategies employed by participants for management of SARS-CoV-2-positive or suspected SARS-CoV-2-positive patients
| Variable | % | |
|---|---|---|
| Area where | ||
| Operating room or anesthetic room | 549/729 | 75.3% |
| Designated block area | 29/729 | 4.0% |
| Negative pressure room | 85/729 | 11.7% |
| Type of PPE used by the practitioner while providing | ||
| Droplet and contact precautions | 174/605 | 28.8% |
| Airborne precautions | 420/605 | 69.4% |
| Other | 11/605 | 1.8% |
| Area where | ||
| Operating room or anesthetic room | 508/729 | 69.7% |
| Designated block area | 61/729 | 8.4% |
| Negative pressure room | 100/729 | 13.7% |
| Type of PPE used by the practitioner while providing | ||
| Droplet and contact precautions | 163/602 | 27.1% |
| Airborne precautions | 430/602 | 71.4% |
| Other | 9/602 | 1.5% |
| Attempting to minimize oxygen flow during surgery under RA (without GA) for a patient suspected or positive for SARS-CoV-2 infection | ||
| No | 145/605 | 24.0% |
| Yes | 460/605 | 76.0% |
| Requiring that a surgical mask is worn by a SARS-CoV-2 suspected or positive patient undergoing a surgical procedure under RA | ||
| No | 27/605 | 4.5% |
| Yes | 578/605 | 95.5% |
| Preferred practice regarding the use of a surgical mask should a patient suspected or positive for SARS-CoV-2 infection undergoing a surgical procedure under RA mask need supplemental oxygen | ||
| Oxygen mask, with a surgical mask layered over the oxygen mask | 121/577 | 21.0% |
| Oxygen mask, with a surgical mask layered under the oxygen mask | 89/577 | 15.4% |
| Nasal prongs (cannula), with a surgical mask layered over the nasal prongs | 351/577 | 60.8% |
| Other methods | 16/577 | 2.8% |
Data are presented as valid number/total number (n/total N) and valid percentage (%)
GA = general anesthesia NAB = neuraxial block; PAPR = powered air-purified respirator; PNB = peripheral nerve block; PPE = personal protective equipment; RA = regional anesthesia
Multivariable binary logistic regression analysis for determinants of expanded use of neuraxial blocks during the height of the COVID-19 pandemic
| Variable | B | SE | Wald | df | Exp(B) | 95% CI for EXP(B) | ||
|---|---|---|---|---|---|---|---|---|
| Lower | Upper | |||||||
| Age (years) | − 0.038 | 0.014 | 7.275 | 1 | 0.963 | 0.936 | 0.990 | |
| Male sex (=1)a | − 0.257 | 0.249 | 1.068 | 1 | 0.30 | 0.773 | 0.474 | 1.260 |
| Country of practice | 6.103 | 4 | 0.19 | |||||
| Europe (=1)b | 0.029 | 0.321 | 0.008 | 1 | 0.93 | 1.030 | 0.549 | 1.933 |
| UK (=1)b | 0.859 | 0.441 | 3.786 | 1 | 0.05 | 2.360 | 0.994 | 5.604 |
| Asia (=1)b | 0.469 | 0.415 | 1.280 | 1 | 0.26 | 1.598 | 0.709 | 3.602 |
| Africa/Australia and New Zealand (=1)b | − 0.144 | 0.697 | 0.042 | 1 | 0.84 | 0.866 | 0.221 | 3.394 |
| Practitioner's category staff/faculty/consultant (=1)c | 0.114 | 0.396 | 0.083 | 1 | 0.77 | 1.121 | 0.516 | 2.436 |
| Setting of practice | ||||||||
| Academic institute/university hospital (=1)d | 0.073 | 0.336 | 0.047 | 1 | 0.83 | 1.075 | 0.557 | 2.077 |
| Military/Veterans Affairs hospital (=1)e | − 0.893 | 0.885 | 1.017 | 1 | 0.31 | 0.409 | 0.072 | 2.322 |
| Community hospital (=1)f | 0.310 | 0.359 | 0.744 | 1 | 0.39 | 1.363 | 0.674 | 2.756 |
| Private clinic (=1)g | 0.702 | 0.332 | 4.477 | 1 | 2.018 | 1.053 | 3.869 | |
| Area of practice predominantly obstetric or mix of obstetric and non-obstetric surgery (=1)h | − 0.183 | 0.252 | 0.527 | 1 | 0.47 | 0.833 | 0.508 | 1.365 |
| Subspecialty | ||||||||
| Orthopedic surgery (=1)i | 0.018 | 0.513 | 0.001 | 1 | 0.97 | 1.018 | 0.373 | 2.780 |
| Trauma surgery (=1)j | − 0.306 | 0.308 | 0.984 | 1 | 0.32 | 0.737 | 0.402 | 1.348 |
| Plastic surgery (=1)k | 0.037 | 0.250 | 0.022 | 1 | 0.88 | 1.038 | 0.636 | 1.695 |
| General surgery including urology (=1)l | 0.271 | 0.333 | 0.664 | 1 | 0.42 | 1.312 | 0.683 | 2.517 |
| NAB preferred to GA before pandemic (=1)m | − 0.122 | 0.350 | 0.121 | 1 | 0.73 | 0.885 | 0.446 | 1.757 |
| Area SA performed before the pandemic | ||||||||
| Operating room or anesthetic room (=1)n | 0.586 | 0.624 | 0.882 | 1 | 0.35 | 1.798 | 0.529 | 6.113 |
| Designated block area (=1)o | 0.415 | 0.589 | 0.497 | 1 | 0.48 | 1.515 | 0.477 | 4.808 |
| Area PNB performed before the pandemic | ||||||||
| Operating room or anesthetic room (=1)p | 0.026 | 0.284 | 0.008 | 1 | 0.93 | 1.026 | 0.588 | 1.793 |
| Designated block area (=1)q | 0.409 | 0.469 | 0.759 | 1 | 0.38 | 1.505 | 0.600 | 3.772 |
| Increased use of PNB during the height of COVID-19 pandemic (=1)r | 2.699 | 0.248 | 118.647 | 1 | 14.865 | 9.146 | 24.159 | |
| Constant | − 0.142 | 1.202 | 0.014 | 1 | 0.91 | 0.868 | ||
*“Pre-COVID-19 preference for PNB” was omitted because of collinearity
aReferenced to “female sex” (= 0)
bReferenced to “Americas” (= 0)
cReferenced to “practitioner’s category other than staff/faculty/consultant” (= 0)
dReferenced to “setting other than academic institute/university hospital” (= 0)
eReferenced to “setting other than military/Veterans Affairs hospital” (= 0)
fReferenced to “setting other than community hospital” (= 0)
gReferenced to “setting other than private clinic” (= 0)
hReferenced to “area of practice predominantly non-obstetric” (= 0)
iReferenced to “subspecialty other than orthopedic surgery” (= 0)
jReferenced to “subspecialty other than trauma surgery” (= 0)
kReferenced to “subspecialty other than plastic surgery” (= 0)
lReferenced to “subspecialty other than general surgery including urology” (= 0)
mReferenced to “GA is preferred to NAB before pandemic” (= 0)
nReferenced to “NAB performed at area other than operating room before pandemic” (= 0)
oReferenced to “NAB performed at area other than an RA-designated area before pandemic” (= 0)
pReferenced to “PNB performed at area other than operating room before pandemic” (= 0)
qReferenced to “PNB performed at area other than an RA-designated area before pandemic” (= 0)
rReferenced to “use of PNB decreased or remained the same during height of COVID-19 pandemic” (= 0)
B = regression coefficient; CI = confidence interval; df = degree of freedom; Exp(B) = adjusted odds ratio; GA = general anesthesia; NAB = neuraxial block; PNB = peripheral nerve block; SA = spinal anesthesia; SE = standard error; Wald = Wald statistic
Multivariable binary logistic regression analysis for determinants of expanded use of peripheral nerve blocks during the height of the COVID-19 pandemic
| Variable* | B | SE | Wald | df | Exp(B) | 95% CI for EXP(B) | ||
|---|---|---|---|---|---|---|---|---|
| Lower | Upper | |||||||
| Age (years) | 0.032 | 0.014 | 4.803 | 1 | 0.03 | 1.032 | 1.003 | 1.062 |
| Male sex (= 1)a | 0.063 | 0.249 | 0.064 | 1 | 0.80 | 1.065 | 0.654 | 1.735 |
| Country of practice | 4.582 | 4 | 0.33 | |||||
| Europe (= 1)b | 0.082 | 0.336 | 0.060 | 1 | 0.81 | 1.086 | 0.562 | 2.096 |
| UK (= 1)b | 0.213 | 0.440 | 0.234 | 1 | 0.63 | 1.237 | 0.523 | 2.929 |
| Asia (= 1)b | 0.569 | 0.422 | 1.820 | 1 | 0.18 | 1.766 | 0.773 | 4.036 |
| Africa/Australia and New Zealand (= 1)b | 1.258 | 0.751 | 2.803 | 1 | 0.09 | 3.517 | 0.807 | 15.331 |
| Practitioner's category staff/faculty/consultant (= 1)c | 0.043 | 0.399 | 0.012 | 1 | 0.92 | 1.044 | 0.478 | 2.280 |
| Setting of practice | ||||||||
| Academic institute/university hospital (= 1)d | − 0.331 | 0.354 | 0.877 | 1 | 0.35 | 0.718 | 0.359 | 1.436 |
| Military/Veterans Affairs hospital (= 1)e | 1.096 | 0.891 | 1.511 | 1 | 0.22 | 2.991 | 0.521 | 17.165 |
| Community hospital (= 1)f | − 0.528 | 0.375 | 1.980 | 1 | 0.16 | 0.590 | 0.283 | 1.230 |
| Private clinic (= 1)g | − 0.762 | 0.348 | 4.806 | 1 | 0.03 | 0.467 | 0.236 | 0.922 |
| Area of practice predominantly obstetric or mix of obstetric and non-obstetric surgery (= 1)h | 0.505 | 0.256 | 3.899 | 1 | 0.048 | 1.656 | 1.004 | 2.733 |
| Subspecialty | ||||||||
| Orthopedic surgery (= 1)i | 0.243 | 0.540 | 0.203 | 1 | 0.65 | 1.276 | 0.442 | 3.677 |
| Trauma surgery (= 1)j | 0.171 | 0.310 | 0.306 | 1 | 0.58 | 1.187 | 0.647 | 2.178 |
| Plastic surgery (= 1)k | 0.082 | 0.252 | 0.106 | 1 | 0.74 | 1.086 | 0.662 | 1.781 |
| General surgery including urology (= 1)l | − 0.703 | 0.340 | 4.272 | 1 | 0.04 | 0.495 | 0.254 | 0.964 |
| NAB preferred to GA before pandemic (= 1)m | − 0.063 | 0.347 | 0.033 | 1 | 0.86 | 0.939 | 0.475 | 1.854 |
| Area SA performed before the pandemic | ||||||||
| Operating room or anesthetic room (= 1)n | − 0.473 | 0.624 | 0.576 | 1 | 0.45 | 0.623 | 0.183 | 2.115 |
| Designated block area (= 1)o | 0.514 | 0.572 | 0.807 | 1 | 0.37 | 1.672 | 0.545 | 5.128 |
| Area PNB performed before the pandemic | ||||||||
| Operating room or anesthetic room (= 1)p | 0.043 | 0.287 | 0.023 | 1 | 0.88 | 1.044 | 0.595 | 1.833 |
| Designated block area (= 1)q | − 0.337 | 0.485 | 0.483 | 1 | 0.49 | 0.714 | 0.276 | 1.847 |
| Increased use of NAB during the height of COVID-19 pandemic (= 1)r | 2.701 | 0.248 | 118.738 | 1 | 14.901 | 9.166 | 24.223 | |
| Constant | − 2.648 | 1.277 | 4.301 | 1 | 0.04 | 0.071 | ||
*“Pre-COVID-19 preference for NAB” was omitted because of collinearity
aReferenced to “female sex” (= 0)
bReferenced to “Americas” (= 0)
cReferenced to “practitioner’s category other than staff/faculty/consultant” (= 0)
dReferenced to “setting other than academic institute/university hospital” (= 0)
eReferenced to “setting other than military/Veterans Affairs hospital” (= 0)
fReferenced to “setting other than community hospital” (= 0)
gReferenced to “setting other than private clinic” (= 0)
hReferenced to “area of practice predominantly non-obstetric” (= 0)
iReferenced to “subspecialty other than orthopedic surgery” (= 0)
jReferenced to “subspecialty other than trauma surgery” (= 0)
kReferenced to “subspecialty other than plastic surgery” (= 0)
lReferenced to “subspecialty other than general surgery including urology” (= 0)
mReferenced to “GA is preferred to NAB before pandemic” (= 0)
nReferenced to “NAB performed at area other than operating room before pandemic” (= 0)
oReferenced to “NAB performed at area other than an RA-designated area before pandemic” (= 0)
pReferenced to “PNB performed at area other than operating room before pandemic” (= 0)
qReferenced to “PNB performed at area other than an RA-designated area before pandemic” (= 0)
rReferenced to “use of PNB decreased or remained the same during height of COVID-19 pandemic” (= 0)
B = regression coefficient; CI = confidence interval; df = degree of freedom; Exp(B) = adjusted odds ratio; GA = general anesthesia; NAB = neuraxial block; PNB = peripheral nerve block; SA = spinal anesthesia; SE = standard error; Wald = Wald statistic